Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1125 of 2529 entries
View as:

Evaluation of the Metabolic Effects of LCZ696 and Amlodipine in Obese Hypertensive Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01631864 Org: User:
Start: 10/31/12 End: 07/31/13 Due: 07/31/14

Safety and Efficacy of SAF312 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Lesions

Phase: N/A Priority: Normal
NCT ID: NCT01598103 Org: User:
Start: 01/31/12 End: 09/30/12 Due: 09/30/13

Efficacy and Safety of Brolucizumab 6mg in a Treat and Extend Regimen in Patients With Neovascular Age-Related Macular Degeneration (nAMD) With Prior Anti-VEGF Exposure (PEREGRINE)

Phase: N/A Priority: Normal
NCT ID: NCT04697953 Org: User:
Start: 05/31/21 End: 05/31/25 Due: 05/31/26

Single and Multiple Dose Escalation Study to Assess the Safety and Tolerability of CJM112 in Psoriasis

Phase: N/A Priority: Normal
NCT ID: NCT01828086 Org: User:
Start: 06/30/13 End: 10/31/15 Due: 10/31/16

Safety and Efficacy of Desferasirox in Chinese Patients With Iron Overload and Aplastic Anemia

Phase: N/A Priority: Normal
NCT ID: NCT01546415 Org: User:
Start: 10/31/11 End: 11/30/13 Due: 11/30/14

Eltrombopag Phase III Study In Chinese Chronic ITP Patients

Phase: N/A Priority: Normal
NCT ID: NCT01762761 Org: User:
Start: 02/18/13 End: 11/22/18 Due: 11/22/19

Real-world Evaluation of Brolucizumab for the Treatment of Neovascular (Wet) Age-related Macular Degeneration (AMD) (Komodo Health)

Phase: N/A Priority: Normal
NCT ID: NCT05111743 Org: User:
Start: 06/17/20 End: 12/18/20 Due: 12/18/21

Study to Evaluate Nilotinib in Chronic Myelogenous Leukemia (CML) Patients With SubOptimal Response

Phase: N/A Priority: Normal
NCT ID: NCT01043874 Org: User:
Start: 12/31/09 End: 01/31/14 Due: 01/31/15

Efficacy/Safety of Valsartan Plus Amlodipine and Valsartan Alone in Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT00413413 Org: User:
Start: 01/31/07 End: 11/30/07 Due: 11/30/08

Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins

Phase: N/A Priority: Normal
NCT ID: NCT01859455 Org: User:
Start: 07/31/11 End: 07/31/12 Due: 07/31/13

A Study to Assess the Efficacy and Safety of CMK389 in Patients With Moderate to Severe Atopic Dermatitis.

Phase: N/A Priority: Normal
NCT ID: NCT04836858 Org: User:
Start: 04/20/21 End: 12/13/22 Due: 12/13/23

Study to Evaluate the Safety and Efficacy of Secukinumab 300 mg and 150 mg in Adult Patients With Active Psoriatic Arthritis (PsA) After 16 Weeks of Treatment Compared to Placebo

Phase: N/A Priority: Normal
NCT ID: NCT02798211 Org: User:
Start: 06/27/16 End: 12/05/18 Due: 12/05/19

A Phase Ib Dose De-escalation Study With BYL719 in Premenopausal Patients With Locally Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02058381 Org: User:
Start: 05/06/14 End: 06/19/18 Due: 06/19/19

Safety and Efficacy of RLX030 in Pregnant Women With Pre- Eclampsia

Phase: N/A Priority: Normal
NCT ID: NCT01566630 Org: User:
Start: 05/31/13 End: 08/31/14 Due: 08/31/15

Drug Use Investigation for REVOLADE (ITP)

Phase: N/A Priority: Normal
NCT ID: NCT01416311 Org: User:
Start: 12/21/10 End: 10/16/20 Due: 10/16/21

SD, IL-13 Production Rate in IPF

Phase: N/A Priority: Normal
NCT ID: NCT00532233 Org: User:
Start: 09/30/07 End: 06/30/09 Due: 06/30/10

Efficacy and Tolerability of Zoledronic Acid With Radiotherapy in Pts With Advanced Osteolytic Bone Lesions

Phase: N/A Priority: Normal
NCT ID: NCT00171964 Org: User:
Start: 05/31/02 End: 12/31/08 Due: 12/31/09

Nilotinib, for Patients With CML-CP or CML-AP

Phase: N/A Priority: Normal
NCT ID: NCT04518644 Org: User:
Start: - End: - Due: -

Efficacy and Safety of RAD001 in Treating Plexiform Neurofibromas (PN) Associated With Neurofibromatosis (NF1)

Phase: N/A Priority: Normal
NCT ID: NCT01365468 Org: User:
Start: 04/30/12 End: 04/30/15 Due: 04/30/16

Efficacy and Safety of QMF149 vs. Salmeterol Xinafoate/Fluticasone Propionate in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01636076 Org: User:
Start: 11/30/12 End: 09/30/13 Due: 09/30/14

A Study to Evaluate the Effects of Once Daily Doses of AQW051 on Cognition, in Stable Schizophrenia Patients

Phase: N/A Priority: Normal
NCT ID: NCT01730768 Org: User:
Start: 09/30/12 End: 12/31/13 Due: 12/31/14

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Chinese Patients With Neovascular Age-Related Macular Degeneration

Phase: N/A Priority: Normal
NCT ID: NCT04047472 Org: User:
Start: 11/29/19 End: 02/28/24 Due: 02/28/25

An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Which Fulfilled the Requirements for the Primary Objective

Phase: N/A Priority: Normal
NCT ID: NCT02116803 Org: User:
Start: 05/28/14 End: 11/28/16 Due: 11/28/17

Real-World Patient Characteristics, Treatment Patterns, and Clinical Outcomes Among Patients With BRAF-Positive Metastatic Melanoma

Phase: N/A Priority: Normal
NCT ID: NCT06251934 Org: User:
Start: 09/28/22 End: 11/24/22 Due: 11/24/23

ASA404 or Placebo in Combination With Paclitaxel and Carboplatin as First-Line Treatment for Stage IIIb/IV Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00662597 Org: User:
Start: 04/30/08 End: 05/31/10 Due: 05/31/11